{
    "2018-03-07": [
        [
            {
                "time": "2018-03-08",
                "original_text": "Shire plc (SHPG) Ex-Dividend Date Scheduled for March 08, 2018",
                "features": {
                    "keywords": [
                        "Shire plc",
                        "Ex-Dividend",
                        "Scheduled"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-09",
                "original_text": "SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Johnson & Johnson (NYSE: JNJ) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit",
                "features": {
                    "keywords": [
                        "SHAREHOLDER",
                        "ALERT",
                        "Johnson & Johnson",
                        "Class Action"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-03-01",
                "original_text": "U.S. judge says opioid settlement roadblocks may prompt trials",
                "features": {
                    "keywords": [
                        "opioid",
                        "settlement",
                        "roadblocks",
                        "trials"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-03-01",
                "original_text": "Opioid Judge Allows Trial Prep as Settlement Talks Hit Snag",
                "features": {
                    "keywords": [
                        "Opioid",
                        "Judge",
                        "Trial Prep",
                        "Settlement Talks"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-03-01",
                "original_text": "Will Recent Trade War Talk Affect the Health Care Sector in March?",
                "features": {
                    "keywords": [
                        "Trade War",
                        "Health Care Sector"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-03-01",
                "original_text": "Why Gilead Sciences’ Harvoni Lost Market Share in 4Q17",
                "features": {
                    "keywords": [
                        "Gilead Sciences",
                        "Harvoni",
                        "Market Share"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-03-01",
                "original_text": "Johnson & Johnson’s Pharmaceutical Segment in 4Q17",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Pharmaceutical Segment"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}